
200 mg UDPG or placebo respectively were administered after an observation period of 1 week to two randomly constructed groups of patients aged 15-35 yr with acute viral hepatitis but no prior history of disease. In the treated patients, mean decreases were most marked and most rapid in the case of SGOT, SGPT, alkaline phosphatase and total bilirubinaemia. These results offer good reason for supposing that UDPG can be usefully employed in the management of acute viral hepatitis.
Adult, Male, Uridine Diphosphate Glucose, Clinical Trials as Topic, Adolescent, Hepatitis, Viral, Human, Bilirubin, Alkaline Phosphatase, Uridine Diphosphate Sugars, Acute Disease, Humans, Female, Transaminases
Adult, Male, Uridine Diphosphate Glucose, Clinical Trials as Topic, Adolescent, Hepatitis, Viral, Human, Bilirubin, Alkaline Phosphatase, Uridine Diphosphate Sugars, Acute Disease, Humans, Female, Transaminases
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
